ASCO 2022: Plenary Presentation in Colorectal Cancer

In this episode, we continue to highlight research presented at the 2022 ASCO Annual Meeting. We’ll first hear a discussion between two researchers on Plenary Abstract LBA1, which may establish a standard first-line combination regimen for patients with RAS wild-type and left-sided metastatic colorectal cancer. Then, we’ll hear about a study that highlighted the need to increase participation in clinical trials among Black women with metastatic breast cancer.

---